Papel de vortioxetina en el tratamiento del dolor neuropático

  title={Papel de vortioxetina en el tratamiento del dolor neurop{\'a}tico},
  author={Antonio Alc{\'a}ntara Montero and S.R. Pacheco de Vasconcelos},
  journal={Revista Espa{\~n}ola de Anestesiolog{\'i}a y Reanimaci{\'o}n},
1 Citations

Presente y futuras perspectivas en el abordaje farmacológico del dolor neuropático

Although the first-line drugs in the treatment of NP include, among others, anticonvulsants, the latest studies question the role of pregabalin, which leads us to consider periodic updates of the guidelines necessary for better clinical practice.



Vortioxetine versus other antidepressants in the treatment of Burning Mouth Syndrome: an open-label randomized trial.

Vortioxetine was efficacious with a shorter latency of action and fewer AEs compared with other ADs, and was associated with a significant decrease in the VAS, T-PRI,HAM-A, HAM-D, CGI-I and CGI-E scores in the long-term.

Vortioxetine in the Treatment of Mood Disorders Associated with Burning Mouth Syndrome: Results of an Open-Label, Flexible-Dose Pilot Study.

VO is efficacious and well tolerated in the treatment of BMS in firstline therapy on account of its better receptor pharmacological profile and in second-line treatment for patients who have only partially responded or have reported adverse effects to previous treatments.

Desvenlafaxina y dolor neuropático: beneficios clínicos adicionales de un inhibidor de la recaptación de serotonina-noradrenalina de segunda generación

La desvenlafaxina presenta unas caracteristicas farmacocineticas interesantes, como son no ser sustrato ni actuar sobre the glicoproteina P y tener un metabolismo that practicamente no depende del sistema del citocromo P450, lo that limita el riesgo of interacciones farmacOCinetic asociados.

Relación entre características del dolor crónico y los niveles de depresión

An attempt is made to study variables such as intensity, time and origin (nature) of pain and to identify their relationship to the patient's state of mind to assess chronic pain.